An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

NCT03611751 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1020

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: BMS-986165
OTHER: Placebo
DRUG: Apremilast

Sponsor

Bristol-Myers Squibb